Pharma · Private company
Eisai Inc.
Track this companyFree. Adds Eisai Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- Lecanemab IVPhase 3 · Early Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Lecanemab SCPhase 3 · Early Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- E7386Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- LenvatinibPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Perampanel Oral SuspensionPhase 2 · Pediatric Epileptic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Perampanel TabletPhase 2 · Pediatric Epileptic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- E1018Phase 1 · MalariaClinicalTrials.gov · fetched Nov 12, 2026
- E2086Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- E7386Phase 1 · Advanced NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- H3B-6545 (150, 300, 450 mg)Phase 1 · Receptors, EstrogenClinicalTrials.gov · fetched Nov 12, 2026
- Palbociclib (75, 100, 125 milligram [mg])Phase 1 · Receptors, EstrogenClinicalTrials.gov · fetched Nov 12, 2026
- LenvatinibCarcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- No InterventionAlzheimers DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- No InterventionAlzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Postmarketing Study of LEQEMBI in Participants With Alzheimer's DiseaseNOT_YET_RECRUITING · started Oct 30, 2026ClinicalTrials.gov NCT07864623 · fetched Nov 12, 2026
- A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsPHASE1 · RECRUITING · started Aug 12, 2026ClinicalTrials.gov NCT07766369 · fetched Nov 12, 2026
- A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's DiseaseACTIVE_NOT_RECRUITING · started May 11, 2026ClinicalTrials.gov NCT07723950 · fetched Nov 12, 2026
- Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)ACTIVE_NOT_RECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07849660 · fetched Nov 12, 2026
- Merck IIT: RRP Pembro and LenvatinibPHASE2 · RECRUITING · started Jul 18, 2025ClinicalTrials.gov NCT04645602 · fetched Nov 12, 2026
- A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's DiseaseRECRUITING · started May 23, 2025ClinicalTrials.gov NCT07821658 · fetched Nov 12, 2026
- A Study of Oral E1018 in Healthy Adult ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 26, 2025ClinicalTrials.gov NCT06854042 · fetched Nov 12, 2026
- DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseasePHASE3 · ACTIVE_NOT_RECRUITING · started Jun 10, 2024ClinicalTrials.gov NCT06384573 · fetched Nov 12, 2026
- DORA and LP in Alzheimer's Disease BiomarkersPHASE2 · RECRUITING · started Mar 11, 2024ClinicalTrials.gov NCT06274528 · fetched Nov 12, 2026
- A Community-Based Screening Program to Identify Participants at High Risk for Amyloid PathologyACTIVE_NOT_RECRUITING · started Sep 12, 2023ClinicalTrials.gov NCT06043700 · fetched Nov 12, 2026
- Lemborexant in Delayed Sleep Phase SyndromePHASE4 · RECRUITING · started Feb 1, 2022ClinicalTrials.gov NCT05463861 · fetched Nov 12, 2026
- Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain MetastasesPHASE2 · RECRUITING · started Jan 20, 2022ClinicalTrials.gov NCT05064280 · fetched Nov 12, 2026
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 22, 2021ClinicalTrials.gov NCT05269394 · fetched Nov 12, 2026
- Scalp Cooling in MBCPHASE2 · RECRUITING · started Oct 7, 2021ClinicalTrials.gov NCT04986579 · fetched Nov 12, 2026
- A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 14, 2021ClinicalTrials.gov NCT04736706 · fetched Nov 12, 2026
- A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)PHASE3 · ACTIVE_NOT_RECRUITING · started Feb 25, 2021ClinicalTrials.gov NCT04586231 · fetched Nov 12, 2026
- Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 2, 2020ClinicalTrials.gov NCT04209660 · fetched Nov 12, 2026
- A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 1, 2020ClinicalTrials.gov NCT04288089 · fetched Nov 12, 2026
- A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 11, 2019ClinicalTrials.gov NCT04008797 · fetched Nov 12, 2026
- A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood EpilepsyPHASE2 · ACTIVE_NOT_RECRUITING · started May 31, 2019ClinicalTrials.gov NCT04015141 · fetched Nov 12, 2026
- A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseasePHASE3 · ACTIVE_NOT_RECRUITING · started Mar 27, 2019ClinicalTrials.gov NCT03887455 · fetched Nov 12, 2026
- Study of E7386 in Participants With Selected Advanced NeoplasmsPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 27, 2017ClinicalTrials.gov NCT03264664 · fetched Nov 12, 2026
- A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 26, 2016ClinicalTrials.gov NCT02623972 · fetched Nov 12, 2026
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 1, 2012ClinicalTrials.gov NCT01760005 · fetched Nov 12, 2026
- National Pregnancy Registry for Psychiatric MedicationsRECRUITING · started Nov 1, 2008ClinicalTrials.gov NCT01246765 · fetched Nov 12, 2026